ArticlePloS one2014

U12, a UDCA derivative, acts as an anti-hepatoma drug lead and inhibits the mTOR/S6K1 and cyclin/CDK complex pathways.

Yang Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.